Impact of comorbidities on real-world (rw) clinical outcomes of patients (pts) with hormone receptor-positive/human epidermal growth factor 2-negative (HR+/HER2−) advanced breast cancer (ABC) treated with palbociclib and enrolled in POLARIS - Tripathy, D; Blum, JL; Karuturi, MS (Ann Oncol, 2023)